The goal is not bigger portions
Many people manage fatigue with simple lifestyle changes
Tirzepatide is a new drug that has shown promising results in clinical trials for weight loss
Search trends indicate rising engagement with terms like bad bacteria overgrowth, gut imbalance, and probiotic benefits, particularly among consumers exploring non-prescription pathways for managing weight gain, fatigue, and appetite fluctuation
Individual health conditions, lifestyle factors, and unique metabolic profiles must be considered to ensure safety and effectiveness
(ZIP 1383 kb) Figure S1: Changes in free proline content and MDA activity during the four treatments (25 C, 25 C + GABA, 4 C and 4 C + GABA for T1, T2, T3 and T4, respectively)